Participated in NexCure's $19M Series A to enable CAR-T and advanced treatment delivery in community outpatient settings.
NexCure partners with health systems to build and operate outpatient treatment centers focusing on CAR-T and T-cell engagers, integrating AI-powered patient selection and remote monitoring
NexCure partners with health systems to build and operate outpatient treatment centers focusing on CAR-T and T-cell engagers, integrating AI-powered patient selection and remote monitoring.